Journal List > J Korean Soc Radiol > v.63(1) > 1086844

TOOLS
Lee, Nam, Chang, and Choe: Prostate Cancer Associated with Mediastinal and Pleural Metastasis: A Case Report
Chest Radiology
Case Report

Journal of the Korean Society of Radiology 2010; 63(1): 41-43.

Published online: 31 July 2010

DOI: https://doi.org/10.3348/jksr.2010.63.1.41

Prostate Cancer Associated with Mediastinal and Pleural Metastasis: A Case Report

Tae Kil Lee, M.D., Ji Eun Nam, M.D., Sun Jung Chang, M.D.2, Kyu-Ok Choe, M.D.

1Department of Radiology, Yonsei University College of Medicine, Korea.

2Department of Pathology, Yonsei University College of Medicine, Korea.

Address reprint requests to: Ji Eun Nam, M.D., Department of Radiology, Yonsei University College of Medicine, 134 Shinchon-dong, Seodaemun-ku, Seoul 120-752, Korea. Tel. 82-2-2228-7400, Fax. 82-2-393-3035, jitane@yuhs.ac

Received 12 January 2010       Accepted 28 April 2010

Copyright © 2010 The Korean Society of Radiology

Abstract

Mediastinal and pleural metastasis of prostate cancer is very rare. To our knowledge, there have been no reported cases of prostate cancer associated with mediastinal metastasis and pleural seeding nodules. We report a histopathologically confirmed case of mediastinal and pleural metastasis originating from prostate cancer by biopsy, which on initial diagnosis, was suspected as being a malignant thymic tumor with pleural metastasis.

Keywords: Prostate Neoplasms, Neoplasms Metastasis, Mediastinum

Figures and Tables

Fig. 1

A. Chest radiograph shows huge bulging mass in the anterior mediastinum.

B. The mediastinal setting of the contrast enhanced chest CT scan shows huge lobulated mass with internal necrosis in the anterior mediastinum.
C. CT scan obtained below the level of Fig. 1B shows multiple pleural seeding nodules (arrows) along the posterior pleura in bilateral lungs.
D. FDG-PET/CT scan shows mild FDG uptake on anterior mediastinal mass.
E. The tumor cell is positive immunoreactivity for PSA (stain with brown color).
jksr-63-41-g001

References

1. Park SK, Sakoda LC, Kang D, Chokkalingam AP, Lee E, Shin HR, et al. Rising prostate cancer rates in South Korea. Prostate. 2006; 66:1285–1291.
2. Koutsilieris M. Skeletal metastases in advanced prostate cancer: cell biology and therapy. Crit Rev Oncol Hematol. 1995; 18:51–64.
3. Long MA, Husband JE. Features of unusual metastases from prostate cancer. Br J Radiol. 1999; 72:933–941.
4. Bubendorf L, Schopfer A, Wagner U, Sauter G, Moch H, Willi N, et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol. 2000; 31:578–583.
5. Moura FM, Garcia LT, Castro LP, Ferrari TC. Prostate adenocarcinoma manifesting as generalized lymphadenopathy. Urol Oncol. 2006; 24:216–219.
6. McGarry RC. Superior vena cava obstruction due to prostate carcinoma. Urology. 2000; 55:436.
7. Kosugi S, Mizumachi S, Kitajima A, Igarashi T, Hamada T, Kaya H, et al. Prostate cancer with supraclavicular lymphadenopathy and bulky abdominal tumor. Intern Med. 2007; 46:1135–1138.
8. Alanen KA, Kuopio T, Koskinen PJ, Nevalainen TJ. Immunohistochemical labelling for prostate specific antigen in non-prostatic tissues. Pathol Res Pract. 1996; 192:233–237.
9. Effert PJ, Bares R, Handt S, Wolff JM, Bull U, Jakse G. Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose. J Urol. 1996; 155:994–998.
TOOLS
Similar articles